bgcolor="#ffffff" align="center" colspan="2" |
Famotidine |
align="center" colspan="2" | 3-[2-(diaminomethyleneamino)thiazol-
4-ylmethylthio]-N-sulfamoylpropionamidine |
CAS number
76824-35-6 | ATC code
|
| bgcolor="#eeeeee" | Chemical formula | bgcolor="#ddeeff" | C8H15N7O2S3 |
| bgcolor="#eeeeee" | Molecular weight | bgcolor="#ddeeff" | 337.5 |
| bgcolor="#eeeeee" | Bioavailability | bgcolor="#ddeeff" | 40-45% |
| bgcolor="#eeeeee" | Metabolism | bgcolor="#ddeeff" | hepatic |
| bgcolor="#eeeeee" | Elimination half-life | bgcolor="#ddeeff" | 2-3.5 hours |
| bgcolor="#eeeeee" | Excretion | bgcolor="#ddeeff" | renal |
| bgcolor="#eeeeee" | Pregnancy category | bgcolor="#ddeeff" | B1 (Australia) |
| bgcolor="#eeeeee" | Legal status | bgcolor="#ddeeff" | Schedule 4 (Aust)
POM (UK) |
| bgcolor="#eeeeee" | Routes of administration | bgcolor="#ddeeff" | oral |